PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months

Clinical trial NCT07333352 · COMPLETED

Trial details

NCT number: NCT07333352
Sponsor: Reinovax Biologics Co., LTD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Infectious Disease

Start date: 2025-09-11
Primary completion: 2026-04-14
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.